Standard Biotools Stock Price Patterns
| LAB Stock | USD 1.24 0.04 3.13% |
Momentum 59
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.02) | EPS Estimate Current Year (0.11) | EPS Estimate Next Year (0.04) | Wall Street Target Price 1.55 | Quarterly Revenue Growth (0.14) |
Using Standard Biotools hype-based prediction, you can estimate the value of Standard Biotools from the perspective of Standard Biotools response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Standard Biotools using Standard Biotools' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Standard using crowd psychology based on the activity and movement of Standard Biotools' stock price.
Standard Biotools Short Interest
A significant increase or decrease in Standard Biotools' short interest from the previous month could be a good indicator of investor sentiment towards Standard. Short interest can provide insight into the potential direction of Standard Biotools stock and how bullish or bearish investors feel about the market overall.
200 Day MA 1.2868 | Short Percent 0.0414 | Short Ratio 5.66 | Shares Short Prior Month 10.3 M | 50 Day MA 1.458 |
Standard Biotools Hype to Price Pattern
Investor biases related to Standard Biotools' public news can be used to forecast risks associated with an investment in Standard. The trend in average sentiment can be used to explain how an investor holding Standard can time the market purely based on public headlines and social activities around Standard Biotools. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Standard Biotools' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Standard Biotools.
Standard Biotools Implied Volatility | 1.41 |
Standard Biotools' implied volatility exposes the market's sentiment of Standard Biotools stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Standard Biotools' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Standard Biotools stock will not fluctuate a lot when Standard Biotools' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Standard Biotools to buy its stock at a price that has no basis in reality. In that case, they are not buying Standard because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Standard Biotools after-hype prediction price | USD 1.3 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Standard contract
Based on the Rule 16, the options market is currently suggesting that Standard Biotools will have an average daily up or down price movement of about 0.0881% per day over the life of the 2026-05-15 option contract. With Standard Biotools trading at USD 1.24, that is roughly USD 0.001093 . If you think that the market is fully incorporating Standard Biotools' daily price movement you should consider acquiring Standard Biotools options at the current volatility level of 1.41%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Standard Biotools Basic Forecasting Models to cross-verify your projections. Standard Biotools After-Hype Price Density Analysis
As far as predicting the price of Standard Biotools at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Standard Biotools or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Standard Biotools, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Standard Biotools Estimiated After-Hype Price Volatility
In the context of predicting Standard Biotools' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Standard Biotools' historical news coverage. Standard Biotools' after-hype downside and upside margins for the prediction period are 0.07 and 5.80, respectively. We have considered Standard Biotools' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Standard Biotools is dangerous at this time. Analysis and calculation of next after-hype price of Standard Biotools is based on 3 months time horizon.
Standard Biotools Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Standard Biotools is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Standard Biotools backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Standard Biotools, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.25 | 4.49 | 0.02 | 0.01 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.24 | 1.30 | 1.56 |
|
Standard Biotools Hype Timeline
On the 5th of February Standard Biotools is traded for 1.24. The entity has historical hype elasticity of 0.02, and average elasticity to hype of competition of 0.01. Standard is forecasted to increase in value after the next headline, with the price projected to jump to 1.3 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 1.56%, whereas the daily expected return is now at 0.25%. The volatility of related hype on Standard Biotools is about 13205.88%, with the expected price after the next announcement by competition of 1.25. The company reported the last year's revenue of 174.43 M. Reported Net Loss for the year was (138.88 M) with profit before taxes, overhead, and interest of 81.9 M. Considering the 90-day investment horizon the next forecasted press release will be in about 8 days. Check out Standard Biotools Basic Forecasting Models to cross-verify your projections.Standard Biotools Related Hype Analysis
Having access to credible news sources related to Standard Biotools' direct competition is more important than ever and may enhance your ability to predict Standard Biotools' future price movements. Getting to know how Standard Biotools' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Standard Biotools may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| VREX | Varex Imaging Corp | 0.02 | 9 per month | 3.01 | 0.07 | 3.76 | (2.67) | 17.42 | |
| CBLL | CeriBell | 0.13 | 9 per month | 2.14 | 0.23 | 6.82 | (3.94) | 18.00 | |
| CGEM | Cullinan Oncology LLC | (0.45) | 10 per month | 3.64 | 0.14 | 8.60 | (6.16) | 45.76 | |
| AVNS | Avanos Medical | 0.08 | 11 per month | 1.71 | 0.13 | 4.68 | (3.06) | 9.85 | |
| SY | So Young International | 0.07 | 5 per month | 5.32 | 0.03 | 7.04 | (8.60) | 31.96 | |
| ADCT | ADC Therapeutics SA | 0.05 | 10 per month | 0.00 | (0.03) | 8.49 | (7.06) | 22.84 | |
| TMCI | Treace Medical Concepts | 0.29 | 9 per month | 0.00 | (0.28) | 5.60 | (5.71) | 31.38 | |
| KIDS | Orthopediatrics Corp | 0.25 | 8 per month | 2.14 | 0 | 3.72 | (2.97) | 16.89 | |
| CTKB | Cytek Biosciences | (0.06) | 8 per month | 2.49 | 0.09 | 6.42 | (4.88) | 26.01 | |
| BVS | Bioventus | (0.04) | 5 per month | 2.07 | 0.09 | 5.12 | (3.49) | 22.05 |
Standard Biotools Additional Predictive Modules
Most predictive techniques to examine Standard price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Standard using various technical indicators. When you analyze Standard charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Standard Biotools Predictive Indicators
The successful prediction of Standard Biotools stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Standard Biotools, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Standard Biotools based on analysis of Standard Biotools hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Standard Biotools's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Standard Biotools's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 6.05 | 7.34 | 6.61 | 5.2 | Days Of Inventory On Hand | 134.09 | 164.9 | 189.63 | 196.27 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Standard Stock analysis
When running Standard Biotools' price analysis, check to measure Standard Biotools' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Biotools is operating at the current time. Most of Standard Biotools' value examination focuses on studying past and present price action to predict the probability of Standard Biotools' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Biotools' price. Additionally, you may evaluate how the addition of Standard Biotools to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |